BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6176449)

  • 1. Significance of the presence of tumor associated antigens in the clinical evolution of the ovarian carcinoma: analysis of 13 cases in stage III and IV.
    Sacco F; Benedetti Panici P; Margariti PA; Di Roberto P; Maiorca A; Muscatello P; Villani L; Iacobelli S
    Eur J Gynaecol Oncol; 1980 Dec; 1(3):136-9. PubMed ID: 6176449
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor markers in the ovarian carcinoma.
    Margariti PA; Benedetti Panici P; Villani L; Di Roberto P; Maiorca A; Sacco F; Bompiani A
    Eur J Gynaecol Oncol; 1980 May; 1(2):77-9. PubMed ID: 6174341
    [No Abstract]   [Full Text] [Related]  

  • 3. Oncofetal antigens in ovarian cyst fluids.
    Kraly DH; Koh SH; Hay DL; Cauchi MN
    Gynecol Obstet Invest; 1984; 18(3):117-21. PubMed ID: 6208091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic monitoring of cervical carcinoma.
    Almerigogna F; Borri P; Buzzoni P; Locatelli F; Savino L
    Eur J Gynaecol Oncol; 1980 Dec; 1(3):164-7. PubMed ID: 6176450
    [No Abstract]   [Full Text] [Related]  

  • 5. The value of tumor markers in cancer of the ovary.
    Cantarow WD; Stolbach LL; Bhattacharya M; Chatterjee SK; Barlow JJ
    Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1095-8. PubMed ID: 6170620
    [No Abstract]   [Full Text] [Related]  

  • 6. Contributions of immunocytochemistry to the diagnosis and study of ovarian neoplasms.
    Kurman RJ; Ganjei P; Nadji M
    Int J Gynecol Pathol; 1984; 3(1):3-26. PubMed ID: 6203854
    [No Abstract]   [Full Text] [Related]  

  • 7. Oncofoetal antigens in cancer of the cervix and ovary.
    Cauchi MN; Koh SH; Lim D; Hay DL
    Br J Cancer; 1981 Sep; 44(3):403-9. PubMed ID: 6169360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma.
    Panza N; Pacilio G; Campanella L; Peluso G; Battista C; Amoriello A; Utech W; Vacca C; Lombardi G
    Cancer; 1988 Jan; 61(1):76-83. PubMed ID: 2446734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour markers in ovarian cancer.
    van Nagell JR
    Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of measurement of several oncofetal antigens in diagnosis and management of epithelial ovarian tumors.
    Massi GB; Amunni G; Tommasi M; Bonazza M; Ciardetti P; Cappelli G
    Eur J Gynaecol Oncol; 1983; 4(2):88-93. PubMed ID: 6191984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated antigens in polyps and carcinoma of the human large bowel.
    Skinner JM; Whitehead R
    Cancer; 1981 Mar; 47(6):1241-5. PubMed ID: 6164469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CA 125, CA 15.3, CA 27.29, CEA, beta-hCG and alpha-fetoprotein levels in cyst fluid of breast macrocysts.
    Martínez L; Castilla JA; Blanco N; Perán F; Herruzo A
    Int J Gynaecol Obstet; 1995 Feb; 48(2):187-92. PubMed ID: 7540567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor antigens in ovarian malignancy.
    Rubin SC; Lewis JL
    Clin Obstet Gynecol; 1986 Sep; 29(3):693-704. PubMed ID: 2428553
    [No Abstract]   [Full Text] [Related]  

  • 15. Significance of tumour markers in ovarian cancer.
    Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
    Indian J Cancer; 1987 Mar; 24(1):1-8. PubMed ID: 2448222
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor markers in urology.
    Grossman HB
    Semin Urol; 1985 Feb; 3(1):10-7. PubMed ID: 2408306
    [No Abstract]   [Full Text] [Related]  

  • 17. [Course studies by means of tumor markers].
    Quentmeier A
    Aktuelle Probl Chir Orthop; 1980; 74():43-6. PubMed ID: 6156606
    [No Abstract]   [Full Text] [Related]  

  • 18. Ovarian tumours markers: clinical experiences.
    Maggino T; Tredese F; Paternoster D; Marchesoni D; Valente S; Inguscio D; Marchetti M
    Eur J Gynaecol Oncol; 1982; 3(2):81-7. PubMed ID: 6187572
    [No Abstract]   [Full Text] [Related]  

  • 19. Ovarian tumor antigens.
    Benson MD; Lurain JR; Newton M
    J Reprod Med; 1983 Jan; 28(1):17-23. PubMed ID: 6187917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of CEA, AFP, SP1 and HCG as tumor markers in ovarian carcinoma.
    Pulay T; Csömör S; Mészáros K; Szarka G; Csabay L; Szinnyai A
    Neoplasma; 1987; 34(5):595-600. PubMed ID: 2447510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.